SPRY Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues CLDI Q4 2025 Earnings Significant EPS Beat Despite No Revenue Onconetix Inc ONCO Q1 2025 Earnings Positive EPS Amidst Minimal Reported Revenue PCVX Q1 2026 Earnings Wider Than Expected Loss as PreRevenue Biotech Advances Vaccine Pipeline INCR Q2 2023 Earnings EPS Surprises 2868 Above Estimates Despite Negative Stock Reaction CVR Q3 2023 Earnings Narrowing Loss Amid Stable Operations